Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer-Reference-Cited by-同舟云学术

Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer

Published:2018-01-12 Issue:5 Volume:31 Page:791-808
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Rosenbaum Jason N^ORCID,Bloom Ryan,Forys Jason T,Hiken Jeff,Armstrong Jon R,Branson Julie,McNulty Samantha,Velu Priya D,Pepin Kymberlie,Abel Haley,Cottrell Catherine E,Pfeifer John D,Kulkarni Shashikant,Govindan Ramaswamy,Konnick Eric Q,Lockwood Christina M,Duncavage Eric J

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2017181.pdf

Reference78 articles.

1. WHO. Cancer Fact Sheet, 2017. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/ (accessed on 23 March 2017).

2. Society AC. Cancer facts & figures, 2017. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html (accessed on 17 January 2017).

3. Soda M, Choi YL, Enomoto M et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007;448:561–566.

4. Choi YL, Takeuchi K, Soda M et al. Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. Cancer Res 2008;68:4971–4976.

5. Perner S, Wagner PL, Demichelis F et al. EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia 2008;10:298–302.

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the treatment of non-small cell lung cancer;PLOS ONE;2024-02-06

2. Serum Protein Fishing for Machine Learning-Boosted Diagnostic Classification of Small Nodules of Lung;ACS Nano;2024-01-25

3. Impact of non-canonical ALK fusion on the efficacy of targeted therapy in non-small cell lung cancer;Chinese Medical Journal;2023-11-29

4. Localised ALK-positive histiocytosis in lung with EML4::ALK fusion;Pathology;2023-11

5. Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple ALK fusions treated with tyrosine kinase inhibitors;Translational Lung Cancer Research;2023-09